Presentation is loading. Please wait.

Presentation is loading. Please wait.

Pain Morning Report Robin Staib, PharmD December 22, 2011.

Published byGeorgina Short Modified over 9 years ago

Similar presentations

Presentation on theme: "Pain Morning Report Robin Staib, PharmD December 22, 2011."— Presentation transcript:

1 Pain Morning Report Robin Staib, PharmD December 22, 2011

2 Equianalgesic Doses (100%) 1)4mg IV morphine ______ PO morphine 4mg IV M x 3 = 12mg PO morphine 2)2mg IV dilaudid ______ PO dilaudid 2mg IV M x5 = 10mg PO dilaudid 3)50mcg IV fentanyl _______ IV morphine 0.05mg x 10/0.1= 5mg IV morphine 4)30mg PO morphine _______ PO oxycodone 30mg PO M x 20mg PO O/30mg PO M = 20mg PO oxy 5)12mg PO dilaudid _______ PO morphine 12mg PO D x 30mg PO M/7.5mg PO D = 48mg PO morphine (7.5:30) 1:3 1:5 0.1:10 30:20 7.5:30

3 Patient 1

4 69 y/o male with Multiple Myeloma (MM) and ESRD on PD who presents with a 2 wk hx of R sided pleuritic thoracic back pain ▫Thoracic x-ray shows compression fx at T11, T12 and diffuse lytic lesions Home Pain regimen ▫oxycodone IR 5mg #180 (30mg oxy/day) Hospital regimen ▫oxycontin 10mg BID, oxycodone IR 5-10mg Q4 hrs prn, & hydromorphone IV 0.25mg Q 3 hrs prn

5 Pt stating pain 10/10 ▫24 hr pain medication utilization:  Oxycontin (10mg bid) = 20mg  Oxycodone IR (5-10mg Q 4hrs prn) = 50mg  Hydromorphone IV (0.25mg Q 3hrs prn) = 0 How would you adjust pt’s pain regimen A) Increase oxycodone 10-15mg Q 3 hrs prn B) Increase Hydromorphone IV dose 0.5mg Q 3hrs prn C) Increase Oxycontin to 20mg BID (20 to 40) D) Increase Oxycontin to 10mg TID (20 to 30) Goal is to use orals 80-120mg

6 After the increase to Oxycontin 20mg BID pt still complaining of 10/10 pain Do you feel patient would benefit from a fentanyl patch? ▫A) Yes ▫B) No

7 Fentanyl Patch Indicated for the management of persistent mod-to- severe pain when around the clock pain control is needed  Criteria met? Not for use in opioid-naïve patients ▫Pt should be tolerating a stable dose of at least 30mg oral morphine or its equivalent/day before placing 12mcg/hr patch  Criteria Met? (70mg oxy = ______________) ~100x more potent than morphine ▫(10mcg fentanyl ~ 1mg morphine) 68-105mg morphine

8 So if wanted to start fentanyl patch, which dose would you start? A) Fentanyl 12mcg B) Fentanyl 25mcg C) Fentanyl 50mcg D) Fentanyl 75mcg 70mg Oxy x 30mg Mor /20mg Oxy = 105mg Mor x 0.65 = 68-105mg po morphine PO Morphine mg/24hrs Fentanyl Patch 30-5912 mcg/hr 60-13425 mcg/hr 135-22450 mcg/hr 225-31475 mcg/hr

9 Patient 2

10 20 yo male with right dental swelling; dental abscess Current Pain Regimen Hydromorphone 1-1.5mg IV Q 3hrs prn Morphine 2-4mg IV Q 3hrs prn Pt expected to go to surgery either later today or first thing tomorrow morning How do you want to control pt’s acute pain? A) Continue IV pushes B) Start a PCA

11 PCA 1) Which Opioid? A) Fentanyl B) Hydromorphone C) Morphine 1.5mg IV Hydro = 10 mg IV morphine ** Hydromorphone should not be first line therapy- should be reserved for pt’s unable to tolerate morphine/fentanyl or those who have failed therapy 2) Dose (Basal? Demand?) Basal? Demand ? NO (1.5mg Q 3hrs prn) (4mg Q 3hrs prn)

12 ConcentrationMorphineHydromorphoneFentanyl Infusion Rate (Continuous Rate): ________mg/hr 0-2mg/hr *(1mg/hr) ________mg/hr 0-0.3mg/hr *(0.2mg/hr) ________mcg/hr 0-25mcg/hr *(10mcg/hr) Demand Dose________mg 1-2.5 mg *(1mg) ________mg 0.2-0.4mg *(0.2mg) ________mcg 10-25mcg *(10mcg) Lockout Interval_________min 8-12 min *(12min) _________min 6-12 min *(8min) _________min 4-8 min *(6min) 4 Hr Lockout________mg 30-50 mg ________mg 6-10 mg ________mcg 200-400 mcg 2mg 12min

13 Recommend Demand dose of 2mg Q 12min with a bolus of 2mg Q 2hrs prn Following day, POD1- after extraoral and intraoral I&D R submandibular, sublingual and lateral pharyngeal odontogenic abscess with extraction of #32 ▫Pt used 21 doses (1700-0700) over past 10hrs  21 x 2mg = IV = Oral morphine Plan to convert to oral pain regimen in preparation for discharge 42mg 126mg

14 Oral Pain Regimen? (126mg po morphine/10hrs) A) MS Contin and MSIR B) Fentanyl Patch C) Lortab Elixer D) Percocet Plan: Lortab Elixer 7.5mg hydrocodone/15ml (501mg APAP) Q 4hrs prn pain Morphine IV 2-4mg Q 2hr prn

15 Patient 3

16 35 yo male with necrotizing pancreatitis complaining of severe pain No opioid history Started on Fentanyl IV pushes Fentanyl 50mcg Q2hrs prn ▫50mcg @ 0244 ▫50mcg @ 0439 ▫50mcg @ 0620 Fentanyl 200mcg Q 1hr prn ▫200mcg @0757 ▫200mcg @ 0912 ▫200mcg @ 1129 200mcg Fentanyl = ____mg IV morphine 0.1mg Fentanyl = 10mg IV morphine So 0.2mg = morphine 20mg IV morphine = dilaudid 20 mg IV 3 mg IV

17 PCA ConcentrationFentanyl Infusion Rate (Continuous Rate) ____mcg/hr 0-25mcg/hr (*10mcg/h) Demand Dose_____mcg 0-25mcg (*10mcg) Lockout Interval____min 4-8 min (*6min) 4 Hr Lockout_____mcg 200-400mcg Basal Rate: 0 Demand Dose: 25mcg Q 20min 4Hr Lockout: 225mcg/4hr (56mcg/hr) Over 18hrs used 35doses out of 61 attempts 35 x 25mcg = 875mcg (48mcg/hr) How do you want to adjust pt’s PCA? a)Add basal rate b)Increase demand dose c)Decrease interval d)Change to morphine

18 Patient 4

19 26 yo female admitted 0300 with a new DVT and history of heroin abuse Pt reports being maintained on methadone 100mg daily for heroin withdrawal avoidance What do you do? A) Start Methadone 100mg daily B) Nothing, wait and see if pt actually withdrawals C) Start Methadone 10mg BID and use prn methadone if pt starts having withdrawal sxms D) Add prn IV morphine and call clinic in morning to verify methadone dose

20 Started methadone 10mg BID Pharmacy called SW behavioral health and was told that pt had not been seen for >30days At 36hrs, pt evaluated and was lying in bed calm and without diaphoresis or other obvious signs of withdrawal Discharge occurred within 48hrs and ▫Sparred 80mg/day of methadone administration ▫Avoided potential harm to pt with high dose methadone (>30days) ▫Didn’t increase maintenance demand with our dosing ▫Successfully controlled sxms of withdrawal

21 Patient 5

22 26yo female on oxycontin 80mg TID and dilaudid 8mg Q 3hrs prn Admitted and made NPO including meds for surgery Plan to start dilaudid PCA Would you start a basal rate? And if so what rate? A)1mg/hr B)0.25mg/hr C)0.5mg/hr D)0.75mg/hr 240mg oxycodone x 7.5mg po dilaudid x 1.5mg IV dilaudid --------------------- ------------------- -------------------- = 12-18mg 20mg oxycodone 7.5mg po dilaudid 12/24hrs =0.5 mg/hr 18/24hr = 0.75 mg/hr

23 Thank you and Happy Holidays

Download ppt "Pain Morning Report Robin Staib, PharmD December 22, 2011."

Similar presentations

Opioids and other drugs we use on palliative care

Opioids and other drugs we use on palliative care
Pain Management Drug Therapy Workshop

Pain Management Drug Therapy Workshop
Transdermal pain management

Transdermal pain management
In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.

In-Patient Management of Hyperglycemia Rey Vivo, MD Assistant Professor of Medicine Texas Tech University Health Sciences Center.
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.

Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Surviving Surgery’s Aftermath Judith Handley MD Assistant Professor OUHSC October 5, 2012.

Surviving Surgery’s Aftermath Judith Handley MD Assistant Professor OUHSC October 5, 2012.
New Opioid Formulations: Hope on the Horizon Pamela P. Palmer, MD PhD Professor and Director, UCSF PainCARE Chief Medical Officer, AcelRx Pharmaceuticals,

New Opioid Formulations: Hope on the Horizon Pamela P. Palmer, MD PhD Professor and Director, UCSF PainCARE Chief Medical Officer, AcelRx Pharmaceuticals,
Interaction between MM cells and bone marrow environment critical for tumor growth and propagation osteoclast Myeloma cells Normal bone.

Interaction between MM cells and bone marrow environment critical for tumor growth and propagation osteoclast Myeloma cells Normal bone.
PAIN MANAGEMENT AT THE END OF LIFE KELLI GERSHON, FNP-BC, ACHPN SYMPTOM MANAGEMENT CONSULTANTS (SMC)

PAIN MANAGEMENT AT THE END OF LIFE KELLI GERSHON, FNP-BC, ACHPN SYMPTOM MANAGEMENT CONSULTANTS (SMC)
Pain Management In the Palliative Care Setting M. Thomas Beets MD.

Pain Management In the Palliative Care Setting M. Thomas Beets MD.
Key dosing points: Begin a bowel regimen when opioid therapy is initiated (senna + docusate). For CHRONIC pain, use a scheduled medication regimen. ( ex:

Key dosing points: Begin a bowel regimen when opioid therapy is initiated (senna + docusate). For CHRONIC pain, use a scheduled medication regimen. ( ex:
Calvin Lui, MD PGY2 February 8, 2014.  Common Opioid Agents and Good Starting Dosages  Opioid Conversion  Use of Patient Controlled Analgesia and Good.

Calvin Lui, MD PGY2 February 8,  Common Opioid Agents and Good Starting Dosages  Opioid Conversion  Use of Patient Controlled Analgesia and Good.
Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.

Pain Policy Update Opioid Update Stuart Beatty, PharmD, BCPS.
Palliative Care Focus on Suffering instead of pain Bernard P Sweeney, MD Medical Director, Teresa House Geneseo, NY.

Palliative Care Focus on Suffering instead of pain Bernard P Sweeney, MD Medical Director, Teresa House Geneseo, NY.
Sublingual Buprenorphine and Pain

Sublingual Buprenorphine and Pain
UMMS CRIT Module III: Opioid Management: Considerations for Older Adults Petra Flock, MD, MSc,CMD Division of Geriatrics University of Massachusetts Medical.

UMMS CRIT Module III: Opioid Management: Considerations for Older Adults Petra Flock, MD, MSc,CMD Division of Geriatrics University of Massachusetts Medical.
Pain Management 101: Basic Skills for Opioid Prescribing

Pain Management 101: Basic Skills for Opioid Prescribing
Opioid therapy for pain

Opioid therapy for pain
A Practical Approach to Cancer Pain Management

A Practical Approach to Cancer Pain Management
Prof. Krishna Boddu. MBBS, MD, DNB, FANZCA, MMEd MBBS, MD, DNB, FANZCA, MMEd University of Texas Health Sciences at Houston, Texas, USA University of Western.

Prof. Krishna Boddu. MBBS, MD, DNB, FANZCA, MMEd MBBS, MD, DNB, FANZCA, MMEd University of Texas Health Sciences at Houston, Texas, USA University of Western.

Similar presentations

Ads by Google